Protocol changes to the TRIUMPH study

American Heart Journal

Volumn 191, Issue , 2017, Pages e1-

  Webster, Ruth ^a  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENDROFLUMETHIAZIDE; CHLORTALIDONE; HYDROCHLOROTHIAZIDE; INDAPAMIDE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; FOLLOW UP; HUMAN; HYPERTENSION; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL;

HUMANS; HYPERTENSION;

EID: 85026302497     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2017.06.015     Document Type: Letter

References (5)

1. Salam, A., Webster, R., Singh, K., et al. TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. Am Heart J 167 (2014), 127–132.
2. Group SR, Wright, J.T. Jr., Williamson, J.D., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
3. National Institute for Health and Clinical Excellence, Clinical management of primary hypertension in adults. NICE clinical guideline 127, 2011.
4. Peterzan, M.A., Hardy, R., Chaturvedi, N., et al. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension 59 (2012), 1104–1109.
5. Olde Engberink, R.H., Frenkel, W.J., van den Bogaard, B., et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension 65 (2015), 1033–1040.